Leo’s Congenital Ichthyosis Candidate Fails Phase III Study
Drug Acquired In Timber Purchase
Executive Summary
TMB-001, a topical formulation of isotretinoin, missed its primary endpoint in the ASCEND study and will not be filed for approval. Leo is turning its attention to hand eczema and dealmaking.